These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19592503)
1. Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay. Hastwell PW; Webster TW; Tate M; Billinton N; Lynch AM; Harvey JS; Rees RW; Walmsley RM Mutagenesis; 2009 Sep; 24(5):455-63. PubMed ID: 19592503 [TBL] [Abstract][Full Text] [Related]
2. GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests. Birrell L; Cahill P; Hughes C; Tate M; Walmsley RM Mutat Res; 2010 Jan; 695(1-2):87-95. PubMed ID: 20006735 [TBL] [Abstract][Full Text] [Related]
3. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187 [TBL] [Abstract][Full Text] [Related]
4. The GADD45a-GFP GreenScreen HC assay. Walmsley RM; Tate M Methods Mol Biol; 2012; 817():231-50. PubMed ID: 22147576 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a higher throughput screening approach to genotoxicity testing using the GADD45a-GFP GreenScreen HC assay. Knight AW; Birrell L; Walmsley RM J Biomol Screen; 2009 Jan; 14(1):16-30. PubMed ID: 19171918 [TBL] [Abstract][Full Text] [Related]
6. An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening. Van Gompel J; Woestenborghs F; Beerens D; Mackie C; Cahill PA; Knight AW; Billinton N; Tweats DJ; Walmsley RM Mutagenesis; 2005 Nov; 20(6):449-54. PubMed ID: 16291732 [TBL] [Abstract][Full Text] [Related]
7. Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: an enabling study for independent validation as an alternative method. Billinton N; Hastwell PW; Beerens D; Birrell L; Ellis P; Maskell S; Webster TW; Windebank S; Woestenborghs F; Lynch AM; Scott AD; Tweats DJ; van Gompel J; Rees RW; Walmsley RM Mutat Res; 2008 May; 653(1-2):23-33. PubMed ID: 18450500 [TBL] [Abstract][Full Text] [Related]
8. Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay. Johnson D; Walmsley R Mutat Res; 2013 Mar; 751(2):96-100. PubMed ID: 23340162 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds. Olaharski A; Albertini S; Kirchner S; Platz S; Uppal H; Lin H; Kolaja K Mutat Res; 2009 Jan; 672(1):10-6. PubMed ID: 18812235 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals. Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the GADD45α-GFP GreenScreen HC assay for rapid and reliable in vitro early genotoxicity screening. Luzy AP; Orsini N; Linget JM; Bouvier G J Appl Toxicol; 2013 Nov; 33(11):1303-15. PubMed ID: 22806210 [TBL] [Abstract][Full Text] [Related]
12. Nongenotoxic apoptosis inducers do not produce misleading positive results in the TK6 cell-based GADD45a-GFP genotoxicity assay. Topham CH; Billinton N; Walmsley RM Toxicol Sci; 2012 Jul; 128(1):79-91. PubMed ID: 22491427 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development. Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335 [TBL] [Abstract][Full Text] [Related]
14. GADD45α induction in the GreenScreen HC indicator assay does not occur independently of cytotoxicity. Olaharski AJ; Albertini S; Mueller L; Zeller A; Struwe M; Gocke E; Kolaja K Environ Mol Mutagen; 2011 Jan; 52(1):28-34. PubMed ID: 20839224 [TBL] [Abstract][Full Text] [Related]
16. The BlueScreen-384 assay as an indicator of genotoxic hazard potential in early-stage drug discovery. Simpson K; Bevan N; Hastwell P; Eidam P; Shah P; Gogo E; Rees S; Brown A J Biomol Screen; 2013 Apr; 18(4):441-52. PubMed ID: 23264450 [TBL] [Abstract][Full Text] [Related]
17. An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC)-including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds. Knight AW; Billinton N; Cahill PA; Scott A; Harvey JS; Roberts KJ; Tweats DJ; Keenan PO; Walmsley RM Mutagenesis; 2007 Nov; 22(6):409-16. PubMed ID: 17906314 [TBL] [Abstract][Full Text] [Related]
18. Development of a high-throughput Gaussia luciferase reporter assay for the activation of the GADD45a gene by mutagens, promutagens, clastogens, and aneugens. Hughes C; Rabinowitz A; Tate M; Birrell L; Allsup J; Billinton N; Walmsley RM J Biomol Screen; 2012 Dec; 17(10):1302-15. PubMed ID: 22786892 [TBL] [Abstract][Full Text] [Related]
19. Ames positive boronic acids are not all eukaryotic genotoxins. Scott H; Walmsley RM Mutat Res Genet Toxicol Environ Mutagen; 2015 Jan; 777():68-72. PubMed ID: 25726177 [TBL] [Abstract][Full Text] [Related]
20. The 'BlueScreen HC' assay as a decision making test in the genotoxicity assessment of flavour and fragrance materials. Etter S; Birrell L; Cahill P; Scott H; Billinton N; Walmsley RM; Smith B Toxicol In Vitro; 2015 Oct; 29(7):1425-35. PubMed ID: 26003925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]